Fig. 5From: The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonistSPECT/CT imaging of 99mTc-SS-04 on HEK-rsst2-xenograft-bearing mouse. Maximum intensity projection (MIP) of the nanoSPECT/CT image acquired 4 h after injection of 15 MBq (150 pmol peptide) 99mTc-SS-04 in a HEK-rsst2-xenograft-bearing mouse. The colour bar corresponds to 0–90%IA/gBack to article page